SBC Medical Group Holdings Incorporated (SBC) is a Consulting Services company in the Industrials sector, currently trading at $4.36. It has a SharesGrow Score of 87/100, indicating a strong investment profile with 6 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of SBC = $6.81 (+56.2% from the current price, the stock appears undervalued). Analyst consensus target is SBC = $9 (+106.4% upside).
Valuation: SBC trades at a trailing Price-to-Earnings (P/E) of 8.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.06.
Financials: revenue is $174M, +0.6%/yr average growth. Net income is $51M, growing at +183.7%/yr. Net profit margin is 29.4% (strong). Gross margin is 73.3% (+7.4 pp trend).
Balance sheet: total debt is $52M against $248M equity (Debt-to-Equity (D/E) ratio 0.21, conservative). Current ratio is 3.78 (strong liquidity). Debt-to-assets is 13.6%. Total assets: $380M.
Analyst outlook: 1 / 1 analysts rate SBC as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 93/100 (Pass), Growth 73/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 58/100 (Partial), Future 100/100 (Pass), Income 85/100 (Pass).
